• 1
    Scott JC, Hochberg MC: Arthritic and other musculoskeletal diseases. In, Chronic Disease Epidemiology and Control. Edited by RCBrownson, PLRemington, JRDavis. Washington, DC, American Public Health Association, 1993
  • 2
    Wilson MG, Poss R: Osteoarthritis of the hip. In, Osteoarthritis: Diagnosis and Medical/Surgical Management. Edited by RWMoskowitz, DSHowell, VMGoldberg, HJMankin. Philadelphia, WB Saunders, 1992
  • 3
    Mow VC, Setton LA, Guilak F, Ratcliffe A: Mechanical factors in articular cartilage and their role in osteoarthritis. In, Osteoarthritic Disorders. Edited by KKuettner, VGoldberg. Rosemont, IL, American Academy of Orthopedic Surgeons, 1995
  • 4
    Poole AR: Imbalances of anabolism and catabolism of cartilage matrix components in osteoarthritis. In, Osteoarthritic Disorders. Edited by KKuettner, VGoldberg. Rosemont, IL, American Academy of Orthopedic Surgeons, 1995
  • 5
    Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K, Brown C, Cooke TD, Daniel W, Feldman D, Greenwald R, Hochberg M, Howell D, Ike R, Kapila P, Kaplan D, Koopman W, Marino C, McDonald E, McShane DJ, Medsger T, Michel B, Murphy WA, Osial T, Ramsey-Goldman R, Rothschild B, Wolfe F: The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34: 505514, 1991
  • 6
    Lorig K, Lubeck D, Kraines RG, Seleznick M, Holman HR: Outcomes of self-help education for patients with arthritis. Arthritis Rheum 28: 680685, 1985
  • 7
    Lorig KR, Mazonson PD, Holman HR: Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs. Arthritis Rheum 36: 439446, 1993
  • 8
    Weinberger M, Tierney WM, Booher P, Katz BP: Can the provision of information to patients with osteoarthritis improve functional status? A randomized, controlled trial. Arthritis Rheum 32: 15771583, 1989
  • 9
    Weinberger M, Tierney WM, Cowper PA, Katz BP, Booher PA: Cost-effectiveness of increased telephone contact for patients with osteoarthritis: a randomized, controlled trial. Arthritis Rheum 36: 243246, 1993
  • 10
    Puett DW, Griffin MR: Published trials of nonmedicinal and noninvasive therapies for hip and knee osteoarthritis. Ann Intern Med 121: 133140, 1994
  • 11
    Minor MA: Exercise in the management of osteoarthritis of the knee and hip. Arthritis Care Res 7: 198204, 1994
  • 12
    Neumann DA: Biomechanical analysis of selected principles of hip joint protection. Arthritis Care Res 2: 146155, 1989
  • 13
    Voloshin D, Wosk J: Influence of artificaial shock absorbers on human gait. Clin Orthop Rel Res 160: 5256, 1981
  • 14
    Minor MA, Hewitt JE, Webel RR, Anderson SK, Kay DR: Efficacy of physical conditioning exercise in patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 32: 13961405, 1989
  • 15
    Silman AJ, Hochberg MC: Epidemiology of the Rheumatic Diseases. Oxford, Oxford University Press, 1993
  • 16
    Panush RS: Is there a role for diet or other questionable therapies in managing rheumatic diseases? Bull Rheum Dis 42: 14, 1993
  • 17
    Brandt KD: Toward pharmacologic modification of joint damage in osteoarthritis. Ann Intern Med 122: 874875, 1995
  • 18
    Batchlor EE, Paulus HE: Principles of drug therapy. In, Osteoarthritis: Diagnosis and Medical/Surgical Management. Edited by RWMoskowitz, DSHowell, VMGoldberg, HJMankin. Philadelphia, WB Saunders, 1992
  • 19
    Brandt KD: Should nonsteroidal anti-inflammatory drugs be used to treat osteoarthritis? Rheum Dis Clin North Am 19: 2944, 1993
  • 20
    Benison H, Kaczynski J, Wallerstedt S: Paracetamol medication and alcohol abuse: a dangerous combination for the liver and the kidney. Scand J Gastroenterol 22: 701704, 1987
  • 21
    Perneger TV, Whelton PK, Klag MJ: Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 331: 16751679, 1994
  • 22
    Sandler DP, Smith JC, Weinberg CR, Buckalew VM Jr, Dennis VW, Blythe WB, Burgess WP: Analgesic use and chronic renal disease. N Engl J Med 320: 12381243, 1989
  • 23
    Sandler DP, Burr FR, Weinberg CR: Nonsteroidal antiinflammatory drugs and risk of chronic renal disease. Ann Intern Med 115: 165172, 1991
  • 24
    Brooks PM, Day RO: Nonsteroidal antiinflammatory drugs: differences and similarities. N Engl J Med 324: 17161725, 1991
  • 25
    Furst DE: Are there differences among nonsteroidal antiinflammatory drugs? Comparing acetylated salicylates, nonacetylated sailcylates, and nonacetylated nonsteroidal antiinflammatory drugs. Arthritis Rheum 37: 19, 1994
  • 26
    Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA: Nonsteroidal antiinflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 114: 257263, 1991
  • 27
    Rashad S, Revell P, Hemmingway A, Low F, Rainsford K, Walker F: Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. Lancet 2: 519522, 1989
  • 28
    Greene JM, Winickoff RN: Cost conscious prescribing of nonsteroidal antiinflammatory drugs for adults with arthritis: a review and suggestions. Arch Intern Med 152: 19952002, 1992
  • 29
    Griffin MR, Brandt KD, Liang MH, Pincus T, Ray WA: Practical management of osteoarthritis: integration of pharmacologic and nonpharmacologic measures. Arch Family Med (in press)
  • 30
    Griffin MR, Ray WA, Schaffner W: Nonsteroidal antiinflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 109: 359363, 1988
  • 31
    Lichtenstein DR, Syngal S, Wolfe MM: Nonsteroidal antiinflammatory drugs and the gastrointestinal tract: the doubleedged sword. Arthritis Rheum 38: 518, 1995
  • 32
    Garell S, Matarese RA: Renal effects of prostaglandins and clinical adverse effects of non-steroidal anti-inflammatory agents. Medicine (Baltimore) 63: 165181, 1984
  • 33
    Barradell LB, Whittington R, Benfield P: Misoprostil: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs. PharmacoEconomics 3: 140170, 1991
  • 34
    Gabriel SE, Jaakkimainen RL, Bombardier C: The costeffectiveness of misoprostol for nonsteroidal antiinflammatory drug–associated adverse gastrointestinal events. Arthritis Rheum 36: 447459, 1993
  • 35
    Stucki G, Johannesson M, Liang MH: Is misoprostil costeffective in the prevention of nonsteroidal antiinflammatory drug-induced gastropathy in patients with chronic arthritis? Arch Intern Med 154: 20202025, 1994
  • 36
    Howell DS, Altman RD, Pelletier JP, Martel-Pelletier J, Dean DD: Disease modifying antirheumatic drugs: current state of their application in animal models of osteoarthritis. In, New Horizons in Osteoarthritis. Edited by KKuettner, VGoldberg. Chicago, American Academy of Orthopedic Surgeons, 1995
  • 37
    Buckwalter JA, Lohmander S: Operative treatment of osteoarthritis: current practice and future development. J Bone Joint Surg [Am] 76: 14051418, 1994
  • 38
    Total Hip Replacement. NIH Consensus Statement 12 (5): 131, 1994
  • 39
    Peterson MGE, Hollenberg JP, Szatrowski TP, Johanson NA, Mancuso CA, Charlson ME: Geographic variations in the rates of elective total hip and knee arthroplasties among Medicare beneficiaries in the United States. J Bone Joint Surg [Am] 74: 15301539, 1992
  • 40
    Lavernia CJ, Guzman JF: Relationship of surgical volume to short-term mortality, morbidity, and hospital charges in arthroplasty. J Arthroplasty 10: 133140, 1995